Abstract:Infectious complications are a common cause of morbidity and mortality in cancer patients undergoing chemotherapy due to increased risk of oral and gastrointestinal candidiasis, candidemia and septicemia. Interactions between C. albicans and endogenous mucosal bacteria are important in understanding the mechanisms of invasive infection. We published a mouse intravenous chemotherapy model that recapitulates oral and intestinal mucositis, and myelosuppression in patients receiving 5-fluorouracil. We used this model to study the influence of C. albicans on the mucosal bacterial microbiome and compared global community changes in the oral and intestinal mucosa of the same mice. We validated 16S rRNA gene sequencing data by qPCR, in situ hybridization and culture approaches. Mice receiving both 5Fu and C. albicans had an endogenous bacterial overgrowth on the oral but not the small intestinal mucosa. C. albicans infection was associated with loss of mucosal bacterial diversity in both sites with indigenous Stenotrophomonas, Alphaproteobacteria and Enterococcus species dominating the small intestinal, and Enterococcus species dominating the oral mucosa. Both immunosuppression and Candida infection contributed to changes in the oral microbiota. Enterococci isolated from mice with oropharyngeal candidiasis were implicated in degrading the epithelial junction protein E-cadherin and increasing the permeability of the oral epithelial barrier in vitro. Importantly, depletion of these organisms with antibiotics in vivo attenuated oral mucosal E-cadherin degradation and C. albicans invasion without affecting fungal burdens, indicating that bacterial community changes represent overt dysbiosis. Our studies demonstrate a complex interaction between C. albicans, the resident mucosal bacterial microbiota and the host environment in pathogenesis. We shed significant new light on the role of C. albicans in shaping resident bacterial communities and driving mucosal dysbiosis.

The Interactions Between <i>Candida albicans</i> and Mucosal Immunity

Interactions between Candida albicans and the resident microbiota

Innate Immune Cell Response Upon Candida Albicans Infection

Innate Immune Cell Response Upon Candida albicans Infection.

The advances in the regulation of immune microenvironment by Candida albicans and macrophage cross-talk

Pathogenesis and virulence of Candida albicans

Effects of interactions between Candida albicans and bacteria on human health and disease

Different Host Immunological Response to C. Albicans by Human Oral and Vaginal Epithelial Cells

Interplay between host and Candida albicans during commensal gut colonization

Effects of Candida Albicans Infection on Defense Effector Secretion by Human Oral Mucosal Epithelial Cells.

Cross-kingdom interaction between Candida albicans and oral bacteria

Candida albicans pathogenicity mechanisms

Candida albicans induces mucosal bacterial dysbiosis that promotes invasive infection

Research progress in the pathogenesis of Candida albicans

Mucosal Immunity to Gut Fungi in Health and Inflammatory Bowel Disease

Tipping the Balance: C. albicans Adaptation in Polymicrobial Environments

Insights into Candida Albicans: A New Perspective on Pathogenic Factors and Regulatory Mechanisms

Adaptive immunity induces mutualism between commensal eukaryotes

A Human Commensal-Pathogenic Fungus Suppresses Host Immunity Via Targeting TBK1

[Progress on the Role of Toll-like Receptors in Candida Albicans Infections].

Candidiasis: From cutaneous to systemic, new perspectives of potential targets and therapeutic strategies